0

HIV Collection
 141-160 of 440 Articles
Abroad |  18 January 2000
Effect of the U.S. Embargo and Economic Decline on Health in Cuba
Michèle Barry, MD
Ann Intern Med. 2000;132(2):151-154. doi:10.7326/0003-4819-132-2-200001180-00010
Technologies of Time |  4 January 2000
Concepts of Time in Clinical Research
Jonathan M. Samet, MD, MS
Ann Intern Med. 2000;132(1):37-44. doi:10.7326/0003-4819-132-1-200001040-00007
Currents |  21 December 1999
Saliva Research Leads to New Diagnostic Tools and Therapeutic Options
Paul T. Kefalides, MD
Ann Intern Med. 1999;131(12):991-992. doi:10.7326/0003-4819-131-12-199912210-00102
Articles |  7 December 1999
HIV-1 Genotypic Resistance Patterns Predict Response to saquinavir–ritonavir Therapy in Patients in Whom Previous Protease Inhibitor Therapy Had Failed
Andrew R. Zolopa, MD; Robert W. Shafer, MD; Ann Warford, PhD; et al.
Ann Intern Med. 1999;131(11):813-821. doi:10.7326/0003-4819-131-11-199912070-00003
MMWR Supplements |  7 December 1999 FREE
1999 USPHS/IDSA Guidelines for the Prevention of Opportunistic Infections in Persons Infected with Human Immunodeficiency Virus
USPHS/IDSA Prevention of Opportunistic Infections Working Group
Ann Intern Med. 1999;131(11):873-908. doi:10.7326/0003-4819-131-11-199912070-00022
Medicine and Public Policy |  16 November 1999
Name-Based Surveillance and Public Health Interventions for Persons with HIV Infection
Dennis H. Osmond, PhD; Andrew B. Bindman, MD; Karen Vranizan, MA; et al.
Ann Intern Med. 1999;131(10):775-779. doi:10.7326/0003-4819-131-10-199911160-00010
Currents |  19 October 1999
Beyond HIV Viral Load Testing
Brigid Kane
Ann Intern Med. 1999;131(8):637-638. doi:10.7326/0003-4819-131-8-199910190-00102
Articles |  5 October 1999 FREE
Drug Resistance Patterns, Genetic Subtypes, Clinical Features, and Risk Factors in Military Personnel with HIV-1 Seroconversion
Stephanie K. Brodine, MD; Richard A. Shaffer, PhD; Monica J. Starkey, MPH; et al.
Ann Intern Med. 1999;131(7):502-506. doi:10.7326/0003-4819-131-7-199910050-00004
Currents |  21 September 1999
Rapid Testing for HIV: Why So Fast?
Brigid Kane
Ann Intern Med. 1999;131(6):481-483. doi:10.7326/0003-4819-131-6-199909210-00101
Articles |  17 August 1999 FREE
Plasma HIV Viral Load in Patients with Hemophilia and Late-Stage HIV Disease: A Measure of Current Immune Suppression
Eric A. Engels, MD, MPH; Philip S. Rosenberg, PhD; Thomas R. O'Brien, MD, MPH; et al.
Ann Intern Med. 1999;131(4):256-264. doi:10.7326/0003-4819-131-4-199908170-00004
Brief Communications |  3 August 1999
The Will To Live among HIV-Infected Patients
Joel Tsevat, MD, MPH; Susan N. Sherman, DPA; Judith A. McElwee, RN; et al.
Ann Intern Med. 1999;131(3):194-198. doi:10.7326/0003-4819-131-3-199908030-00006
Articles |  20 July 1999
Highly Active Antiretroviral Therapy in a Large Urban Clinic: Risk Factors for Virologic Failure and Adverse Drug Reactions
Gregory M. Lucas, MD; Richard E. Chaisson, MD; Richard D. Moore, MD, MHSc
Ann Intern Med. 1999;131(2):81-87. doi:10.7326/0003-4819-131-2-199907200-00002
Ideas and Opinions |  20 July 1999
Optimizing Care for Persons with HIV Infection
Frederick M. Hecht, MD; Ira B. Wilson, MD, MSc; Albert W. Wu, MD; et al.
Ann Intern Med. 1999;131(2):136-143. doi:10.7326/0003-4819-131-2-199907200-00011
Articles |  15 June 1999
Translating Clinical Trial Results into Practice: The Effect of an AIDS Clinical Trial on Prescribed Antiretroviral Therapy for HIV-Infected Pregnant Women
Barbara J. Turner, MD, MSEd; Craig J. Newschaffer, PhD; Daozhi Zhang, MS; et al.
Ann Intern Med. 1999;130(12):979-986. doi:10.7326/0003-4819-130-12-199906150-00005
Currents |  15 June 1999
Have Oxygen, Will Travel
Francie Scott
Ann Intern Med. 1999;130(12):1036. doi:10.7326/0003-4819-130-12-199906150-00018
Articles |  6 April 1999
Relations among CD4 Lymphocyte Count Nadir, Antiretroviral Therapy, and HIV-1 Disease Progression: Results from the EuroSIDA Study
Veronica Miller, PhD; Amanda Mocroft, PhD; Peter Reiss, MD; et al.
Ann Intern Med. 1999;130(7):570-577. doi:10.7326/0003-4819-130-7-199904060-00005
Brief Communications |  16 March 1999
Phase I Studies of Hypericin, the Active Compound in St. John's Wort, as an Antiretroviral Agent in HIV-Infected Adults: AIDS Clinical Trials Group Protocols 150 and 258
Roy M. Gulick, MD, MPH; Vincent McAuliffe, MD; Jeanne Holden-Wiltse, MPH; et al.
Ann Intern Med. 1999;130(6):510-514. doi:10.7326/0003-4819-130-6-199903160-00015
Currents |  16 February 1999
Illiteracy: The Silent Barrier to Health Care
Paul T. Kefalides, MD
Ann Intern Med. 1999;130(4_Part_1):333-336. doi:10.7326/0003-4819-130-4-199902161-00001
Brief Communications |  2 February 1999
Mixed Cryoglobulinemia in HIV-1 Infection: The Role of HIV-1
Antonios N. Dimitrakopoulos, MD; Theodore Kordossis, MD; Angelos Hatzakis, MD; et al.
Ann Intern Med. 1999;130(3):226-230. doi:10.7326/0003-4819-130-3-199902020-00027
Articles |  19 January 1999
The Costs, Clinical Benefits, and Cost-Effectiveness of Screening for Cervical Cancer in HIV-Infected Women
Sue J. Goldie, MD, MPH; Milton C. Weinstein, PhD; Karen M. Kuntz, ScD; et al.
Ann Intern Med. 1999;130(2):97-107. doi:10.7326/0003-4819-130-2-199901190-00003
Advertisement

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)